FDA Approves First Oral GLP-1 Weight-Loss Pill Wegovy
TL;DR Summary
The FDA has approved a daily pill version of Wegovy, a popular anti-obesity drug by Novo Nordisk, offering an alternative to the weekly injection with similar effectiveness in weight loss, and expected to be available in early January for $149 per month.
- FDA Approves Pill Version of Wegovy WIRED
- F.D.A. Approves Wegovy Weight-Loss Pill The New York Times
- The FDA just approved the first GLP-1 weight-loss pill. Here’s what to know. The Washington Post
- Novo Nordisk's new obesity pill, Alphabet's data center deal, the end of EV euphoria and more in Morning Squawk CNBC
- With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 3 min read
Condensed
93%
580 → 42 words
Want the full story? Read the original article
Read on WIRED